Acute rhinosinusitis is a major health concern in the United States; and patients are cared for by a diverse group of physicians and physician extenders whose specialties range from internal medicine and family practice to pulmonology, immunology, pediatrics, and otolaryngology. The wide variety among treating health care professionals makes standardization of the diagnosis a challenge. The aim of this chapter is to review the definition and diagnosis of acute rhinosinusitis in adults and to discuss the associated controversies.

Definition {#Sec1}
==========

In 1997 the Rhinosinusitis Task Force published the first definitions and guidelines for the diagnosis of rhinosinusitis in the otolaryngological literature. In general, rhinosinusitis was defined as a manifestation of an inflammatory response involving the mucous membranes of the sinonasal cavities with or without involvement of the underlying bone. As such, it manifests with symptoms and physical findings over a particular timeframe. To establish a consistent definition among all health care professionals treating patients, major and minor criteria incorporating these symptoms and physical findings were established (see Chapter 1, Table 1.1). A time factor was thought necessary to distinguish various forms of rhinosinusitis including acute, subacute, and chronic. Therefore, acute rhinosinusitis was defined by a sudden onset with symptoms lasting no more than 4 weeks, while subacute rhinosinusitis encompassed symptoms lasting for 4 to 12 weeks (thought to reflect acute rhinosinusitis that had not completely resolved itself). Finally, chronic rhinosinusitis was defined by symptoms lasting more than 12 weeks with either two or more major factors or one major and two minor factors \[[@CR1]\].

Notable in these criteria is that fever and/or facial pressure/pain without other nasal factors do not by themselves constitute a diagnosis of rhinosinusitis. Additionally, in contrast to acute rhinosinusitis, fever is not a major factor in subacute rhinosinusitis as the symptoms overall are less severe in nature. Since the original attempt to clinically define rhinosinusitis in 1997, the guidelines have been enhanced to make them more useful. In the 2007 clinical practice guidelines, acute rhinosinusitis was further subdivided---based on symptom pattern---into acute bacterial rhinosinusitis (ABRS) and viral rhinosinusitis (VRS), which are further discussed under "Presenting Symptoms and Signs \[[@CR2]\]. "

In the 2005 position paper by the European Academy of Allergology and Clinical Immunology, the definition of acute rhinosinusitis is symptom based. Acute rhinosinusitis is defined as the sudden onset of two or more of the following symptoms for less than 12 weeks: blockage/congestion, rhinorrhea/postnasal drip, facial pressure/pain, and reduction/loss of sense of smell. Symptom-free intervals must also exist if the problem is intermittent in nature. Acute viral rhinosinusitis is further defined as symptoms lasting less than 10 days, whereas a worsening of symptoms after 5 days or with persistence of symptoms after 10 days (but less than 12 weeks) constitutes acute nonviral rhinosinusitis \[[@CR3]\].

Pathophysiology {#Sec2}
===============

Acute rhinosinusitis begins with a viral upper respiratory tract infection (URI). Predisposing factors such as allergy, trauma, dental infection, nasal anatomy, and systemic diseases (e.g., vasculitis, granulomatous disease, or immunodeficient states) contribute to the frequency and severity of symptoms. The most common virus implicated in acute rhinosinusitis is human rhinovirus, followed by coronavirus, influenza A and B viruses, parainfluenza virus, respiratory syncytial virus, adenovirus, and enterovirus. Once the virus attaches to epithelial cells, there is an upregulation of inflammatory pathways resulting in the production of histamine, bradykinin, and various cytokines. A downstream effect of this inflammation is the suppression of macrophage and lymphocyte function, which creates a milieu susceptible to bacterial infection and overgrowth \[[@CR4],[@CR5]\].

Bacteria subsequently superinfect the sinonasal mucosa, as shown by repeated sinus aspiration studies demonstrating that 60% of adults with URI symptoms for 10 days or more have significant bacterial growth in sinus cultures. Isolates from maxillary sinus aspirates show that the most common pathogens are *Streptococcus pneumoniae* and *Haemophilus influenzae,* together comprising more than half of the bacterial isolates. Figure [3.1](#Fig3_1_144168_1_En){ref-type="fig"} displays the incidence of bacterial pathogens in acute maxillary rhinosinusitis in an adult population \[[@CR6]\].Fig. 3.1Microbiology of acute bacterial rhinosinusitis in adults

Epidemiology {#Sec3}
============

Acute rhinosinusitis, either viral or bacterial, carries a significant health burden in the United States even with the most conservative estimates. The most recent data from the National Health Interview Study showed that rhinosinusitis is the most common respiratory disease among Americans, with 13% having been told by a doctor that they have rhinosinusitis in the last year. Female respondents were nearly twice as likely to have the diagnosis; and it was also more common in the South than in other regions of the country \[[@CR7]\]. There is a significant cost associated with acute rhinosinusitis, both in health care as well as in the workforce. Rhinosinusitis also ranks in the top 10 most costly physical health conditions affecting U.S. employers \[[@CR8]\].

Given that acute rhinosinusitis has such a high prevalence, it is imperative that health care providers are able to accurately diagnose the condition and appropriately prescribe antibiotics. As one recent study illustrated, 81% of patients diagnosed with acute rhinosinusitis have received antibiotics \[[@CR9]\]. Appropriate use of antibiotics is vital to avoid a further increase in antibiotic resistance \[[@CR10]\]. Prescribing patterns can change the prevalence of specific drug resistance. In Finland, macrolide-resistant group A streptococcal isolates decreased by 50% (from 16.5% to 8.6% of isolates) when new practice guidelines recommended a decrease in macrolide consumption \[[@CR11]\].

Presenting Symptoms and Signs {#Sec4}
=============================

Fever, Nasal Obstruction, Pain, Headache, Purulent Rhinorrhea {#Sec5}
-------------------------------------------------------------

Because a diversity of health care professionals are diagnosing and treating acute rhinosinusitis, the bulk of the diagnosis rests on an individual patient's symptoms and findings on physical examination: purulent nasal drainage, nasal obstruction, and facial pain/pressure/fullness. Although early consensus reports used the major and minor criteria discussed, the more recent reports have strayed from this concept and focused instead on only major symptoms \[[@CR1]--[@CR3]\].

The time-course of the symptoms then becomes the next most important factor in distinguishing VRS from ABRS. VRS tends to be self-limited, with symptoms peaking at day 2 to 3 and then waning with resolution of symptoms between 10 and 14 days after onset. If symptoms initially improve and then subsequently worsen, or if symptoms persist beyond 10 days, the probability of bacterial infection is increased and the diagnosis of ABRS can be made \[[@CR2],[@CR6],[@CR12]\].

On physical examination, anterior rhinoscopy reveals hyperemia of the nasal mucosa and nasal congestion. If purulence is visualized the diagnosis is secured; pain on palpation over the individual sinuses may aid in the diagnosis. Pharyngeal irritation or purulence in the posterior or lateral pharynx can also be used to aid in the proper diagnosis.

Associated Factors {#Sec6}
------------------

During evaluation for acute rhinosinusitis, associated factors must be considered. The European Academy of Allergology and Clinical Immunology (EAACI) recommends a query for allergic symptoms such as sneezing, watery rhinorrhea, nasal itching, and itchy watery eyes \[[@CR3]\]. Although there are limited data, it does appear that individuals with baseline allergic symptoms may be at increased risk for bacterial rhinosinusitis. Alho and colleagues examined 48 individuals during the first days of a viral upper respiratory infection \[[@CR13]\]. Evaluation included a paranasal sinus computed tomography (CT) scan at the initial evaluation and then again after 21 days. The individuals with allergic rhinitis (19%) had significantly poorer CT scan results when compared with nonallergic subjects both initially and at follow-up. These results may indicate impairment in mucociliary clearance with a subsequent predisposition to the development of ABRS \[[@CR13]\].

Other factors that must be considered include unilateral symptoms (foreign body, tumor), history of trauma or prior surgery, presence of immunosuppression or systemic disease (Wegener's granulomatosis, sarcoidosis), or impairments in mucociliary clearance (cystic fibrosis, primary ciliary dyskinesia).

Sinonasal Endoscopy {#Sec7}
-------------------

Examination with a 0° endoscope reveals hyperemia, congestion, crusting, and purulence emanating from the sinuses. The location of the purulence can help in localizing the infection, as purulence in the middle meatus streaming anterior to the eustachian tube orifice originates from the maxillary, anterior ethmoid, and frontal sinuses whereas purulence seen in the sphenoethmoid recess and above the eustachian tube orifice comes from the sphenoid and posterior ethmoid sinuses. Endoscopy yielded a sensitivity of 80% and specificity of 94% in one retrospective review, which was an improvement from the standard used in this study, which was standard X-ray \[[@CR14]\]. Although sinonasal endoscopy is considered standard in an otolaryngological practice, this is not the case for most practitioners who are confronted with the challenge of diagnosing ARS. Therefore, sinonasal endoscopy is not considered necessary for an accurate diagnosis, although it should be utilized if available as this enables the practitioner to culture any purulence that is visualized.

Sinonasal Culture {#Sec8}
-----------------

The gold standard for sinus culture has been the maxillary sinus tap via a trocar through the canine fossa or with a needle through the inferior meatus \[[@CR15]\]. Although this method is considered the standard for pharmaceutical trials, it is impractical in the clinical realm. Patients are unlikely to agree to the procedure secondary to real or perceived discomfort, and most practitioners treating acute bacterial rhinosinusitis (ABRS) are not skilled in performing the procedure. Nasal cavity swabs, although easily performed, have not been shown to reliably identify a causative organism without endoscopic guidance, as these cultures have only a 65% concordance rate with maxillary antral cultures \[[@CR16]\].

With the advent of sinonasal endoscopy, a more directed and less invasive culture technique was introduced. One of the early studies evaluating endoscopic middle meatal cultures (EMMC) was performed by Vogan and colleagues in 2000 \[[@CR17]\]. EMMC and antral puncture were performed on 16 individuals presenting with symptoms of acute rhinosinusitis and maxillary sinus air-fluid levels on CT. This group reported a concordance rate of 93.8% for aerobic culture and 87.4% for anaerobic culture \[[@CR17]\]. Further support for the validity of EMMC was demonstrated by two meta-analyses, the first in 2005 by Dubin et al., that revealed accuracy of 82% per isolate when compared with maxillary sinus aspirates \[[@CR18]\]. Benninger and colleagues then described a sensitivity of 80.9% and specificity of 90.5%, a positive predictive value of 82.6%, a negative predictive value of 89.4%, and an overall accuracy of 87% of EMMC \[[@CR19]\].

Culture-directed therapy, although ideal, has remained elusive in the majority of cases of acute rhinosinusitis. The majority of practitioners treating ABRS do not have endoscopic tools at their disposal and, therefore, cultures are reserved for complex and recalcitrant cases necessitating specialty care.

Laboratory Data {#Sec9}
---------------

Although not routine, serologic markers for inflammation may be helpful in the diagnosis of ABRS. In 1995, Hansen et al. reported on a cohort of 174 patients with physician suspected rhinosinusitis, and the diagnosis was confirmed with maxillary antral puncture in 92 (53%) \[[@CR20]\]. The diagnosis was then correlated with CT imaging, physical signs and symptoms, and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Only an ESR more than 20 mm/h in females and more than 10 mm/h in males, as well as a CRP more than 10 mg/l, were significantly associated with the correct diagnosis \[[@CR20]\]. Other groups have also supported the use of ESR for increasing the positive predictive value of the diagnosis, but this has not been supported as being cost-effective by others \[[@CR3],[@CR21]\].

Imaging {#Sec10}
-------

### Ultrasound {#Sec11}

As a cost-effective means for aiding in the diagnosis of acute maxillary rhinosinusitis, ultrasound has been recommended. Although rapid and noninvasive, the technology is operator dependent and, therefore, has not gained support for standard diagnosis. In one study of 197 adults with symptoms of the common cold, ultrasonography and Waters' view were performed, and magnetic resonance imaging (MRI) was performed randomly on 40 participants on day 7 of the study \[[@CR22]\]. The calculated sensitivity of ultrasonography for the diagnosis of maxillary rhinosinusitis was 64% with a specificity of 95% in this study,\[[@CR22]\] which would indicate that a positive ultrasound could be used to diagnose acute rhinosinusitis. However, a negative exam would have little value.

### X-Ray {#Sec12}

Plain X-ray has been used to evaluate the presence of air-fluid levels or mucosal thickening in the paranasal sinuses. Waters' (occipitomental) view, where the X-ray beam is oriented through the chin, is used to obtain views of the maxillary and frontal sinuses. In the Caldwell view, the X-ray beam is oriented directly through the forehead and is used to evaluate the frontal sinus. In one report, the sensitivity and specificity are somewhat modest at 76% and 79%, respectively \[[@CR23]\]. When evaluating the efficacy of using a single Waters' view for diagnosing acute maxillary versus frontal rhinosinusitis, the accuracy has been shown to be even worse. When evaluating the maxillary sinus, a single Waters' view has a false-negative rate of 32% and a mean negative predictive value of 76.9%; and the sensitivity for evaluating the frontal sinus is only 14.6% when compared to CT. Radiologists in this study also could not commit to a diagnosis when evaluating the ethmoid and sphenoid sinuses, indicating that this modality is not adequate for the evaluation of these sinuses \[[@CR24],[@CR25]\]. Figures [3.2](#Fig3_2_144168_1_En){ref-type="fig"} and [3.3](#Fig3_3_144168_1_En){ref-type="fig"} are plain X-rays of Caldwell and Waters views demonstrating mucosal thickening. These images reveal how the diagnosis of acute rhinosinusitis from X-ray can be difficult. Structural overlapping can lead to the impression of edematous mucosa, a hypoplastic sinus can be misinterpreted as pathological opacification, and infection can be difficult to distinguish from tumor and polyp. Fig. 3.2Caldwell view of the sinuses demonstrating well-pneumatized paranasal sinuses (**A**) versus chronic mucosal thickening (**B**) Fig. 3.3Waters' view demonstrating chronic mucosal thickening

### Computed Tomography {#Sec13}

Computed tomography (CT) in acute rhinosinusitis demonstrates partial or complete opacification, air-fluid levels, and air bubbles within fluid levels in the paranasal sinuses (Fig. [3.4](#Fig3_4_144168_1_En){ref-type="fig"}). This finding contrasts to chronic rhinosinusitis that may show mucosal thickening in addition to complete opacification (Figs. [3.5](#Fig3_5_144168_1_En){ref-type="fig"}, [3.6](#Fig3_6_144168_1_En){ref-type="fig"}, [3.7](#Fig3_7_144168_1_En){ref-type="fig"}). CT, although more sensitive than plain films, is not specific, as demonstrated by partial opacification noted on up to 42% of head CTs performed for various reasons, and unrelated to the paranasal sinuses \[[@CR26]\]. In addition, CT cannot distinguish between viral and bacterial rhinosinusitis, as opacification of the infundibulum and paranasal sinuses can be seen on CT scan 48 h after the onset of cold-type symptoms \[[@CR27]\]. CT radiography has also shown to have no effect on outcome \[[@CR28]\].Fig. 3.4Coronal computed tomography (CT) demonstrating acute maxillary rhinosinusitis Fig. 3.5Coronal CT demonstrating acute maxillary and ethmoid rhinosinusitis with air bubbles within fluid density, indicating purulence in the right maxillary sinus Fig. 3.6Coronal CT demonstrating acute on chronic rhinosinusitis with complete opacification of bilateral ethmoid sinuses, left maxillary sinus mucosal thickening, and air bubbles within the right maxillary sinus indicating purulence Fig. 3.7Coronal CT demonstrating changes associated with chronic rhinosinusitis, including mucosal thickening of bilateral maxillary sinuses

Imaging, independent of the modality, is neither sensitive nor specific when striving to make the diagnosis of acute rhinosinusitis. Therefore, imaging is not recommended as a first-line procedure when evaluating a patient. CT should be reserved for the diagnosis of complicated acute rhinosinusitis, which is discussed in detail below.

Diagnosis of Complicated Acute Rhinosinusitis {#Sec14}
=============================================

Most episodes of acute rhinosinusitis are self-limited and resolve without further sequelae. However, complicated acute rhinosinusitis involves intracranial and intra orbital spread of infection and must be accurately diagnosed for immediate intervention. Orbital extension is demonstrated by periorbital edema, erythema, conjunctival injection, chemosis, proptosis, diplopia, ophthalmoplegia, and/or decreased visual acuity. Orbital complications are thought to be secondary to extension of infection from osteitis of the thin lamina papyracea or via thrombophlebitis of communicating veins \[[@CR29],[@CR30]\]. Diagnosis is best performed by a team including an ophthalmologist and otolaryngologist and should include CT scan of the orbit and sinuses to evaluate the extent of the infection, and complete ophthalmologic examination, as well as endoscopic evaluation.

Intracranial complications of rhinosinusitis include subdural empyema, intracerebral abscess, extradural abscess, and meningitis. Infection spreads most commonly from the frontal sinus through direct spread from osteomyelitis of the skull, by retrograde thrombophlebitis through the small diploic veins of the sinus to the small vessels traversing the dura, or via a defect (surgical or traumatic) that directly connects the sinus to the cranial vault. Adolescent and young males are at highest risk for intracranial complications, which is thought to be secondary to an abundant valveless diploic system providing a good conduit for bacterial infection \[[@CR31]\]. Individuals most commonly present with altered mental status, headache, fever, seizure, vomiting, hemiparesis, or a cranial neuropathy; CT and MRI are used to confirm the diagnosis.

Controversy {#Sec15}
===========

The subjective nature of symptoms-based criteria for the diagnosis of rhinosinusitis presents many challenges. First, interpretation and standardization in the literature are difficult as there is no true "gold standard" with which to compare the various modalities. This problem has been extensively discussed in regard to chronic rhinosinusitis (CRS), as there has been poor correlation between symptoms and findings on CT imaging. For example, Hwang et al. found that 35% of patients with symptoms of CRS had negative CT imaging \[[@CR32]\]. In 2002, Stankiewicz and Chow sought to determine the relationship between symptoms (as defined by the 1997 Rhinology task force), nasal endoscopy, and CT scan \[[@CR33]\]. They found that neither endoscopy nor CT scanning correlated with the symptoms-based criteria for CRS, as more than 50% and 68% of patients who met the criteria for CRS had negative CT scans and normal endoscopic examinations. However, they did find that if purulence, polyps, or polypoid congested mucosa were present on endoscopy, sinus disease was usually present on the CT scan and that a negative endoscopic exam was a relatively good predictor of a negative CT scan \[[@CR33]\].

This observation then brings into question the importance of clinical symptoms, imaging, and nasal endoscopy in acute rhinosinusitis. Given the diversity of health care professionals who are involved with diagnosing ARS, and lack of better noninvasive physical examination techniques, we support the symptoms-based schemes that have been discussed. We also believe that, given the poor sensitivity and specificity of diagnostic imaging, there is little role for this modality in the diagnosis of uncomplicated rhinosinusitis. Endoscopic evaluation on the other hand, if available, should be used as an adjunct in the diagnosis of rhinosinusitis and should be considered before imaging. Endoscopy may aid greatly in the diagnosis of acute rhinosinusitis, especially in two scenarios: when negative, it may help to avoid antibiotic use; and further, for the patient who is not responding to therapy, endoscopically obtained cultures may provide guidance in antibiotic choice.
